Stayble Therapeutics Ab Stock Current Valuation
| STABL Stock | SEK 0.57 0.02 3.64% |
Valuation analysis of Stayble Therapeutics helps investors to measure Stayble Therapeutics' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Stayble Therapeutics' price fluctuation is out of control at this time. Calculation of the real value of Stayble Therapeutics is based on 3 months time horizon. Increasing Stayble Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Stayble stock is determined by what a typical buyer is willing to pay for full or partial control of Stayble Therapeutics AB. Since Stayble Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Stayble Stock. However, Stayble Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.57 | Real 0.53 | Hype 0.57 | Naive 0.51 |
The intrinsic value of Stayble Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Stayble Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Stayble Therapeutics AB helps investors to forecast how Stayble stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Stayble Therapeutics more accurately as focusing exclusively on Stayble Therapeutics' fundamentals will not take into account other important factors: Stayble Therapeutics AB Company Current Valuation Analysis
Stayble Therapeutics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Stayble Therapeutics Current Valuation | 15.2 M |
Most of Stayble Therapeutics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Stayble Therapeutics AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Stayble Therapeutics AB has a Current Valuation of 15.2 M. This is 99.89% lower than that of the Healthcare sector and 99.67% lower than that of the Biotechnology industry. The current valuation for all Sweden stocks is 99.91% higher than that of the company.
Stayble Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Stayble Therapeutics' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Stayble Therapeutics could also be used in its relative valuation, which is a method of valuing Stayble Therapeutics by comparing valuation metrics of similar companies.Stayble Therapeutics is currently under evaluation in current valuation category among its peers.
Stayble Fundamentals
| Return On Equity | -0.76 | |||
| Return On Asset | -0.44 | |||
| Operating Margin | (97.37) % | |||
| Current Valuation | 15.2 M | |||
| Shares Outstanding | 13.85 M | |||
| Shares Owned By Insiders | 32.55 % | |||
| Shares Owned By Institutions | 22.10 % | |||
| Price To Book | 2.85 X | |||
| Price To Sales | 213.81 X | |||
| Gross Profit | 9 K | |||
| EBITDA | (12.03 M) | |||
| Net Income | (12.09 M) | |||
| Cash And Equivalents | 42.71 M | |||
| Cash Per Share | 3.09 X | |||
| Total Debt | 850 K | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 63.53 X | |||
| Book Value Per Share | 1.43 X | |||
| Cash Flow From Operations | (9.63 M) | |||
| Earnings Per Share | (1.27) X | |||
| Beta | 0.76 | |||
| Market Capitalization | 49.02 M | |||
| Total Asset | 43.64 M | |||
| Z Score | 34.2 | |||
| Net Asset | 43.64 M |
About Stayble Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Stayble Therapeutics AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Stayble Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Stayble Therapeutics AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Stayble Stock Analysis
When running Stayble Therapeutics' price analysis, check to measure Stayble Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stayble Therapeutics is operating at the current time. Most of Stayble Therapeutics' value examination focuses on studying past and present price action to predict the probability of Stayble Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stayble Therapeutics' price. Additionally, you may evaluate how the addition of Stayble Therapeutics to your portfolios can decrease your overall portfolio volatility.